Pathol Res Pract

Pathol Res Pract

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

23

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 23 Papers
Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients.

Ge X, Yu Z, Guo X, Li L, Ye L, Ye M, Yuan J, Zhu C, Hu W, Hou Y.

2023 PMID: 37244049
3/7
COI Funding
Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a li…

Calabria E, Canfora F, Mascolo M, Varricchio S, Mignogna MD, Adamo D.

2022 PMID: 35278817
2/7
Funding
Biobanking in times of crisis - The COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg.

Domke LM, Klein IM, Hartmann L, Schwab C, Marx A, Werner M, Möller P, Fend F, Bösmüller H, Schirmac…

2022 PMID: 35841694
3/7
COI Funding
Cell tropism and viral clearance during SARS-CoV-2 lung infection.

Schwab C, Domke LM, Rose F, Hausser I, Schirmacher P, Longerich T.

2022 PMID: 35797854
3/7
COI Funding
RETRACTED: The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study.

Margiana R, Sharma SK, Khan BI, Alameri AA, Opulencia MJC, Hammid AT, Hamza TA, Babakulov SK, Abdel…

2022 PMID: 36137396
3/7
COI Funding
SARS-CoV-2-associated gut microbiome alteration; A new contributor to colorectal cancer pathogenesis.

Mozaffari SA, Salehi A, Mousavi E, Zaman BA, Nassaj AE, Ebrahimzadeh F, Nasiri H, Valedkarimi Z, Ad…

2022 PMID: 36191449
3/7
COI Funding
The role of antigen-presenting cells in the pathogenesis of COVID-19.

Farzi R, Aghbash PS, Eslami N, Azadi A, Shamekh A, Hemmat N, Entezari-Maleki T, Baghi HB.

2022 PMID: 35338971
3/7
COI Funding
Cell death and pathological findings of the spleen in COVID-19 patients.

Ping H, Zhang K, Wang Y, Tong X, Chen Z, Cai C, Lu Z, Gui X, Liu L, Wang X, Ke H.

2021 PMID: 34601398
3/7
COI Funding
COVID-19 and cancer: Sailing through the tides.

Mohanty A, Agnihotri S, Mehta A, Rawal S.

2021 PMID: 33857716
3/7
COI Funding